Objective: To assess the matching between bone marrow aspirate and bone marrow biopsy findings done simultaneously in patients with clinical indications of bone marrow examination, to stand on the diagnostic efficacy of each in various bone marrow diseases.
Introduction
Bone marrow examination is an important diagnostic procedure; it is useful in establishing diagnosis of various hematological and non hematological diseases. It is the process of obtaining the soft liquid tissue (aspirate) and solid trephine piece (biopsy ) of bone marrow for laboratory analysis and diagnosis. Bone marrow aspirate is particularly useful in assessment of marrow cellularity and is considered diagnostic in certain diseases including idiopathic thrombocytopenic purpura (ITP), hematological malignancies, and in typing of anemias.
(3)
Biopsies on the other hand, are of paramount importance in diagnosing certain conditions including aplastic anaemia and myelofibrosis and in defining pattern of involvement of marrow spaces especially in lymphoma and solid tumors,
and granulomatous diseases. The aim of our study is to assess the correlation between bone marrow aspirate and biopsy in various hematological diseases so that efficient procedure is defined for more rapid diagnosis.
Methods
This is a retrospective review that was conducted at King Hussein Medical Center where random 500 bone marrow aspirates were compared with the simultaneously done 500 bone marrow biopsies, between January and December 2012. Only adult patients (18 years of age and older) were included. Bone marrow aspiration and biopsy were performed at the Oncology clinic for both in-patients and out-patients. All patients were provided an explanation of the purpose of the investigation and how the procedure will be carried out and oral consent is usually considered sufficient. The posterior iliac crest (5) is the usual site for the procedure in our hospital. The procedure is performed by an hematology/oncology fellow. Technical expertise (2) is needed to obtain adequate sample. Jamshidi needle or disposable bone marrow needle are most commonly used to draw the aspirate and biopsy, the collected amount for both are operator dependent, the average amount for aspirate was in the range 0.5-1 ml, and 0.5-1cm biopsy length are needed.
Aspirate smears are routinely stained by Geimsa stain while biopsy sections are stained by hematoxylin and eosin stain. This study was approved by the research ethics committee at KHMC.
Results
A total of random 500 reports of bone marrow aspirates were compared to simultaneously done bone marrow biopsy reports. The age range was between 18 to 91 years, the male to female ratio was 1.34:1. The most common indication for bone marrow examination in our study was reviewing the diagnosis and monitoring patients already diagnosed and managed for major hematological malignancies to look for therapy effect, anemia, pancytopenia, and bone marrow staging. Other indications as listed in Table I . The diagnostic findings of bone marrow aspirate, biopsy, and percentage of correlation, respectively, for different diseases are summarised in Table II 
Discussion
Bone marrow examination (aspiration and biopsy) remains a corner stone in the diagnosis of various hematological and non hematological diseases. The correlation between both procedures is important to determine the most diagnostic method in various hematological diseases. The final interpretation requires the integration of peripheral blood, (6) bone marrow aspirate and biopsy findings, together with other ancillary tests such as immunophenotyping, cytogenetic and molecular genetics results in the context of clinical history and clinical picture which can lead to a definitive diagnosis. The pathology report for bone marrow aspirate generally takes less than one day, but about 2-3 days for biopsy. Our findings are similar to what is mentioned in the literature. In this study there was a 76.2% positive correlation between aspirate and biopsy, this is similar to the study published in Pakistan by Khan et al. where the correlation was 78% . The highest correlation was noted in diffuse bone marrow diseases including: acute myeloid leukemia (92.8%), idiopathic thrombocytopenic purpura (91%), and chronic myeloid leukemia (90.9%), this was observed by Khan et al. Chandra et al. (8) and Goyal et al. Chandra et al. (8) and Goyal et al.
(9)
In contrast, bone marrow aspirate has good predictive value and reliable in hematological malignancies, immune thrombocytopenia, and anemias. It has very limited and poor diagnostic in metastatic solid tumor, lymphoma involvement, aplastic anemia and myelofibrosis where biopsy is the standard diagnostic procedure. One hundred forty nine patients were reported to have normal bone marrow aspirate, of them 103 have been proven to be normal (true negative) by correlation with biopsy (69.1%), the other 46 were really considered false negative, most of them were diagnosed by biopsy as lymphoma involvement, metastasis, aplastic anemia and myelofibrosis, this again proves poor diagnostic efficacy of aspirate for these infiltrative bone marrow diseases, these findings were correlated with the Chandra et al. (8) where the correlated normality between aspiration and biopsy was 72.5%.
Seventy three (14.6%) of patients were undiagnosed by bone marrow aspiration, 31 (6.2%) were hemodiluted and inadequate sample, 26 (5.2%) were dry aspirates, and 16 patients have no diagnosis and need bone marrow biopsy correlation, few others were in need for further flow cytometry and cytogenetics. Humphries (10) has reported the frequency of dry aspirate to be 3.9%. The only limitation for diagnostic efficacy of bone marrow biopsy was inadequate samples in 41 patients (8.2%). Rehman et al. (11) reported inadequate specimens in 2007, 2008, and 2009 to be 4.9%, 10.5% and 3.3% respectively, very few cases need further flow cytometry and cytogenetics for the purposes of diagnosis. The present study shows the diagnostic efficacy of both bone marrow aspirate and biopsy to be 76.2% and 98.8% respectively. Khan et al. have reported the diagnostic efficacy of bone marrow aspiration 73.8 % , and 99% for biopsy, Chandra et al. (8) have reported them 77.5% and 99.2% respectively, sensitivity, specificity, positive predictive value and negative predictive value are shown in Table III and IV. Monitoring hematological malignancies for therapy response was the most common indication for bone marrow examination in our study. Other indications are shown in Table I . These indications were to some extent comparable to Bashawri et al. (12) indications for bone marrow examination.
Limitations of the study
We excluded patients who were less than 18 years old. The high percentage of non diagnosed aspirate and hemodiluted biopsies or inadequate samples, which depend on nature of underlying disease and experience of physician obtaining the specimen, may effect the diagnostic efficacy of both. The result of flow cytometry, cytogenetics, and immunohistochemistry were not included in our study.
Conclusion
Bone marrow aspirate is a complementary diagnostic test, it has good predictive value reaching that of biopsy in diffuse bone marrow diseases like: AML, ITP, CML, nutritional and megaloblastic anemia, ALL, hematological malignancy relapse, MM, CLL, PRV, ET, hematological malignancy remission, MDs. On the other hand, aspiration has very limited predictive value in infiltrative bone marrow diseases like: lymphoma, solid tumor metastasis, myelofibrosis, aplastic anemia, unexplained leucoerythroblastic blood film, where biopsy is mandatory.
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